Home/Filings/4/0001225208-09-021700
4//SEC Filing

MERCK SHARP & DOHME CORP. 4

Accession 0001225208-09-021700

CIK 0000064978operating

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 9:08 PM ET

Size

21.3 KB

Accession

0001225208-09-021700

Insider Transaction Report

Form 4
Period: 2009-11-03
Transactions
  • Disposition to Issuer

    Common Stock

    2009-11-032,5000 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-035,0000 total
    Exercise: $47.23From: 2005-04-30Exp: 2014-04-29Common Stock (5,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-035,0000 total
    Exercise: $51.86From: 2008-04-27Exp: 2017-04-26Common Stock (5,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-035,0000 total
    Exercise: $38.04From: 2009-04-30Exp: 2018-04-29Common Stock (5,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-035,0000 total
    Exercise: $24.30From: 2010-05-01Exp: 2019-04-30Common Stock (5,000 underlying)
  • Disposition to Issuer

    Phantom Stock

    2009-11-0322,837.9070 total
    Exercise: $0.00Common Stock (22,837.907 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-035,0000 total
    Exercise: $33.83From: 2006-04-29Exp: 2015-04-28Common Stock (5,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-11-035,0000 total
    Exercise: $34.44From: 2007-04-28Exp: 2016-04-27Common Stock (5,000 underlying)
Footnotes (3)
  • [F1]Disposal of upon the completion of and pursuant to the transactions contemplated by the Agreement and Plan of Merger with, inter alia, Schering-Plough Corporation (the "Transactions") under which Schering-Plough Corporation (renamed as Merck & Co., Inc.) survives (the "Surviving Corporation") and becomes the sole shareholder of Merck & Co., Inc. (renamed Merck Sharp & Dohme Corp.) ("Old Merck"). Such shares of Old Merck common stock are being exchanged pursuant to the Transactions for an equivalent amount of whole and fractional shares of Surviving Corporation common stock. On the effective date of the Transactions, the closing price of Old Merck common stock was $30.67 per share and the closing price of Schering-Plough Corporation common stock was $28.15 per share.
  • [F2]Each share of phantom stock is the economic equivalent of one share of Old Merck common stock, and was granted under the Plan for Deferred Payment of Directors Compensation. The Plan for Deferred Payment of Directors Compensation will be continued after the Transactions and each share of phantom stock will have the economic equivalent of one share of Surviving Corporation Common Stock.
  • [F3]This option to purchase shares of Old Merck common stock, which vesting in three equal annual installments beginning one year from date of grant, was assumed by the Surviving Corporation in the Transactions and continued on the same terms and conditions as an option to purchase an equivalent number of shares of Surviving Corporation Common Stock at the same exercise price as applied prior to the Transactions.

Documents

1 file

Issuer

MERCK SHARP & DOHME CORP.

CIK 0000064978

Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0000064978

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 9:08 PM ET
Size
21.3 KB